Start › Nowotwór przerzutowy › Teksas › San Antonio
Badania kliniczne dla Nowotwór przerzutowy w mieście San Antonio, TX
44 badań dla Nowotwór przerzutowy szuka uczestników w ośrodkach w mieście San Antonio i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekrutacjaFaza 3
- Texas Oncology - San Antonio, San Antonio
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekrutacjaFaza 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekrutacjaFaza 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
RekrutacjaFaza 1/2
- NEXT Oncology, San Antonio
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
RekrutacjaFaza 1
- University of Texas San Antonio (UTSA), San Antonio
A Study of ASP3082 in Adults With Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology, San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology, San Antonio
SLV-154 Treatment of Advanced Cancers
RekrutacjaFaza 1
- Mays Cancer Center; University of Texas Health San Antonio, San Antonio
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekrutacjaFaza 3
- Texas Oncology - San Antonio Medical Center, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekrutacjaFaza 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekrutacjaFaza 1/2
- START South Texas Accelerated Research Therapeutics, San Antonio
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Clinical Study Site, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
RekrutacjaFaza 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT Oncology, San Antonio
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekrutacjaFaza 1/2
- Avenzo Therapeutics Recruiting Site, San Antonio
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
RekrutacjaFaza 1/2
- South Texas Accelerated Research Therapeutics (START) - San Antonio, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekrutacjaFaza 3
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekrutacjaFaza 1
- South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Next Oncology, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
RekrutacjaFaza 1
- START San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
RekrutacjaFaza 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Texas Oncology - San Antonio, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- START San Antonio, LLC., San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekrutacjaFaza 1
- USA Clinical Trials, San Antonio
A Study of PYX-201 in Advanced Solid Tumors
RekrutacjaFaza 1
- NEXT San Antonio, San Antonio
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekrutacjaFaza 1
- NEXT Oncology, San Antonio
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekrutacjaFaza 3
- Jason Bates at University of Texas Health Science Center, San Antonio
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Exelixis Clinical Site #2, San Antonio
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Research Site, San Antonio
CT-95 in Advanced Cancers Associated With Mesothelin Expression
RekrutacjaFaza 1
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekrutacjaFaza 1
- Research Site #2, San Antonio
- Research Site, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekrutacjaFaza 1
- START, San Antonio
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- University of Texas Health Science Center at San Antonio, San Antonio
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
RekrutacjaFaza 1
- NEXT Oncology, San Antonio
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
RekrutacjaFaza 1
- Texas Liver Institute, San Antonio
- NEXT Oncology, San Antonio
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RekrutacjaFaza 3
- Mays Cancer Center, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekrutacjaFaza 1/2
- Next Oncology, San Antonio
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RekrutacjaFaza 1/2
- Next Oncology, San Antonio
- The Start Center for Cancer Care, San Antonio
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekrutacjaFaza 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
- UT Health San Antonio, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
RekrutacjaFaza 1
- UT Health, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- START San Antonio, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
RekrutacjaFaza 1
- NEXT Oncology, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RekrutacjaFaza 1/2
- NEXT Oncology, San Antonio
Badania dla Nowotwór przerzutowy w innych miastach
- Houston, TX104 badań
- New York City, NY93 badań
- Nashville, TN70 badań
- Boston, MA63 badań
- Los Angeles, CA57 badań
- St. Louis, MO54 badań
- Arlington, VA53 badań
- Philadelphia, PA46 badań
- Chicago, IL45 badań
- Washington, DC43 badań
- Dallas, TX42 badań
- Seattle, WA39 badań
Inne badania w mieście San Antonio
- Niedrobnokomórkowy rak płuca59 badań
- Rak piersi47 badań
- Rak jelita grubego i odbytnicy46 badań
- Nowotwory (wszystkie typy)41 badań
- Otyłość40 badań
- Cukrzyca typu 237 badań
- Nadwaga34 badań
- Rak jajnika31 badań
- Rak trzustki31 badań
- Rak prostaty28 badań
- Rak endometrium27 badań
- Rak płuc26 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.